News Novo posts strong performance, but US pricing pressure grows Pharmacy benefit managers and arrival of biosimilars making life difficult for diabetes companies
News Novo to expand world's biggest insulin production site World's largest insulin plant is to get bigger.
News Victoza disappoints on cardio benefits, lifts rival Jardianc... Victoza results are significant, but fell short of investors' expectations.
News Sanofi's diabetes combo on target for showdown with Novo Rival insulin and GLP-1 combinations under review in US.
News Pharma looking to dual-action diabetes drugs to boost sales Pharma using FDA-mandated trials to give a commercial advantage.
News AI specialists Enveda and Basecamp rake in the cash AI-powered drug discovery companies Enveda and Basecamp have completed impressive funding rounds, worth $311m and $140m, respectively.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
